Reply: Timing of pravastatin initiation for preeclampsia prevention

Am J Obstet Gynecol. 2022 Mar;226(3):454. doi: 10.1016/j.ajog.2021.10.011. Epub 2021 Oct 16.

Authors

Devin D Smith¹, Maged M Costantine²

Affiliations

¹ Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Kaiser Permanente, Northern California, 4601 Dale Rd., Modesto, CA 95356. Electronic address: devin.d.smith@post.harvard.edu.
² Department of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, OH.

PMID: 34666054
DOI: 10.1016/j.ajog.2021.10.011

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Pravastatin / therapeutic use
Pre-Eclampsia* / prevention & control
Pregnancy

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pravastatin